Investment Banking
Healthcare & Life Sciences

Synteract Acquires Dermatology CRO Cu-Tech, LLC

Published on
July 11, 2018

Summary

Synteract has snapped up specialty contract researcher Cu-Tech, with plans to establish a dedicated center for the development of dermatology products and make the midsized, global CRO into a destination for skin-care clinical trials.

Mountain Lakes, New Jersey-based Cu-Tech has managed more than 130 dermatology trials over the past two decades, covering a variety of indications. The financial details of the acquisition were not disclosed.

Team Members Involved

Meet the talented individuals who brought their expertise and dedication to this project. Their collaboration, insight, and commitment to excellence were instrumental in delivering impactful results for our clients.

No team members are listed for this project.

Related News Articles

Stay updated with the latest industry news.

Related News Articles

Stay updated with the latest industry news.

Have questions? Our team is here to help

Whether you're seeking guidance on a complex transaction, exploring investment banking possibilities, or looking for wealth management strategies, our team is here to help.

Stay in touch

Provide your email to join our distribution list. By providing your email you consent to receive emails from Salem Partners Wealth Management.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.